186 related articles for article (PubMed ID: 38580754)
1. Proteomic analysis of DEN and CCl
Zhang Q; Liu Y; Ren L; Li J; Lin W; Lou L; Wang M; Li C; Jiang Y
Sci Rep; 2024 Apr; 14(1):8013. PubMed ID: 38580754
[TBL] [Abstract][Full Text] [Related]
2. The DEN and CCl4 -Induced Mouse Model of Fibrosis and Inflammation-Associated Hepatocellular Carcinoma.
Uehara T; Pogribny IP; Rusyn I
Curr Protoc Pharmacol; 2014 Sep; 66():14.30.1-14.30.10. PubMed ID: 25181010
[TBL] [Abstract][Full Text] [Related]
3. Cell expression patterns of CD147 in N-diethylnitrosamine/phenobarbital-induced mouse hepatocellular carcinoma.
Lu M; Wu J; He F; Wang XL; Li C; Chen ZN; Bian H
J Mol Histol; 2015 Feb; 46(1):79-91. PubMed ID: 25447507
[TBL] [Abstract][Full Text] [Related]
4. The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation.
Wu Q; Chen JX; Chen Y; Cai LL; Wang XZ; Guo WH; Zheng JF
Cell Death Dis; 2018 Feb; 9(2):232. PubMed ID: 29445190
[TBL] [Abstract][Full Text] [Related]
5. Bile acids promote diethylnitrosamine-induced hepatocellular carcinoma via increased inflammatory signaling.
Sun L; Beggs K; Borude P; Edwards G; Bhushan B; Walesky C; Roy N; Manley MW; Gunewardena S; O'Neil M; Li H; Apte U
Am J Physiol Gastrointest Liver Physiol; 2016 Jul; 311(1):G91-G104. PubMed ID: 27151938
[TBL] [Abstract][Full Text] [Related]
6. An Immune Gene Expression Signature Associated With Development of Human Hepatocellular Carcinoma Identifies Mice That Respond to Chemopreventive Agents.
Moeini A; Torrecilla S; Tovar V; Montironi C; Andreu-Oller C; Peix J; Higuera M; Pfister D; Ramadori P; Pinyol R; Solé M; Heikenwälder M; Friedman SL; Sia D; Llovet JM
Gastroenterology; 2019 Nov; 157(5):1383-1397.e11. PubMed ID: 31344396
[TBL] [Abstract][Full Text] [Related]
7. Whole transcriptome analysis of chemically induced hepatocellular carcinoma using RNA-sequencing analysis.
Sun J; Wang J; Zhang N; Yang R; Chen K; Kong D
FEBS Open Bio; 2019 Nov; 9(11):1900-1908. PubMed ID: 31433574
[TBL] [Abstract][Full Text] [Related]
8. The DEN and CCl
Uehara T; Pogribny IP; Rusyn I
Curr Protoc; 2021 Aug; 1(8):e211. PubMed ID: 34370903
[TBL] [Abstract][Full Text] [Related]
9. Standardization of diethylnitrosamine-induced hepatocellular carcinoma rat model with time based molecular assessment.
Ghufran H; Azam M; Mehmood A; Butt H; Riazuddin S
Exp Mol Pathol; 2021 Dec; 123():104715. PubMed ID: 34699901
[TBL] [Abstract][Full Text] [Related]
10. Differentially expressed MicroRNAs provide mechanistic insight into fibrosis-associated liver carcinogenesis in mice.
Marrone AK; Shpyleva S; Chappell G; Tryndyak V; Uehara T; Tsuchiya M; Beland FA; Rusyn I; Pogribny IP
Mol Carcinog; 2016 May; 55(5):808-17. PubMed ID: 25865624
[TBL] [Abstract][Full Text] [Related]
11. Mice With Increased Numbers of Polyploid Hepatocytes Maintain Regenerative Capacity But Develop Fewer Hepatocellular Carcinomas Following Chronic Liver Injury.
Lin YH; Zhang S; Zhu M; Lu T; Chen K; Wen Z; Wang S; Xiao G; Luo D; Jia Y; Li L; MacConmara M; Hoshida Y; Singal AG; Yopp A; Wang T; Zhu H
Gastroenterology; 2020 May; 158(6):1698-1712.e14. PubMed ID: 31972235
[TBL] [Abstract][Full Text] [Related]
12. GSTZ1 deficiency promotes hepatocellular carcinoma proliferation via activation of the KEAP1/NRF2 pathway.
Li J; Wang Q; Yang Y; Lei C; Yang F; Liang L; Chen C; Xia J; Wang K; Tang N
J Exp Clin Cancer Res; 2019 Oct; 38(1):438. PubMed ID: 31666108
[TBL] [Abstract][Full Text] [Related]
13. Chronic administration of diethylnitrosamine to induce hepatocarcinogenesis and to evaluate its synergistic effect with other hepatotoxins in mice.
Fuentes-Hernández S; Alarcón-Sánchez BR; Guerrero-Escalera D; Montes-Aparicio AV; Castro-Gil MP; Idelfonso-García OG; Rosas-Madrigal S; Aparicio-Bautista DI; Pérez-Hernández JL; Reyes-Gordillo K; Lakshman MR; Vásquez-Garzón VR; Baltiérrez-Hoyos R; López-González ML; Sierra-Santoyo A; Villa-Treviño S; Pérez-Carreón JI; Arellanes-Robledo J
Toxicol Appl Pharmacol; 2019 Sep; 378():114611. PubMed ID: 31176654
[TBL] [Abstract][Full Text] [Related]
14. TLR4 Deficiency Protects against Hepatic Fibrosis and Diethylnitrosamine-Induced Pre-Carcinogenic Liver Injury in Fibrotic Liver.
Weber SN; Bohner A; Dapito DH; Schwabe RF; Lammert F
PLoS One; 2016; 11(7):e0158819. PubMed ID: 27391331
[TBL] [Abstract][Full Text] [Related]
15. Abberent expression of NOR1 protein in tumor associated macrophages contributes to the development of DEN-induced hepatocellular carcinoma.
Chen S; Zheng P; Wang W; Yi M; Chen P; Cai J; Li J; Peng Q; Ban Y; Zhou Y; Zeng Z; Li X; Xiong W; Li G; Xiang B
J Cell Physiol; 2018 Jun; 233(6):5002-5013. PubMed ID: 29227538
[TBL] [Abstract][Full Text] [Related]
16. Dissection of DEN-induced platelet proteome changes reveals the progressively dys-regulated pathways indicative of hepatocarcinogenesis.
Leng T; Liu N; Dai Y; Yu Y; Zhang C; Du R; Chen X
J Proteome Res; 2010 Dec; 9(12):6207-19. PubMed ID: 20919743
[TBL] [Abstract][Full Text] [Related]
17. TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms.
Esparza-Baquer A; Labiano I; Sharif O; Agirre-Lizaso A; Oakley F; Rodrigues PM; Zhuravleva E; O'Rourke CJ; Hijona E; Jimenez-Agüero R; Riaño I; Landa A; La Casta A; Zaki MYW; Munoz-Garrido P; Azkargorta M; Elortza F; Vogel A; Schabbauer G; Aspichueta P; Andersen JB; Knapp S; Mann DA; Bujanda L; Banales JM; Perugorria MJ
Gut; 2021 Jul; 70(7):1345-1361. PubMed ID: 32907830
[TBL] [Abstract][Full Text] [Related]
18. Metabolic pathway analyses identify proline biosynthesis pathway as a promoter of liver tumorigenesis.
Ding Z; Ericksen RE; Escande-Beillard N; Lee QY; Loh A; Denil S; Steckel M; Haegebarth A; Wai Ho TS; Chow P; Toh HC; Reversade B; Gruenewald S; Han W
J Hepatol; 2020 Apr; 72(4):725-735. PubMed ID: 31726117
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of androgen/AR signaling inhibits diethylnitrosamine (DEN) induced tumour initiation and remodels liver immune cell networks.
Helms TH; Mullins RD; Thomas-Ahner JM; Kulp SK; Campbell MJ; Lucas F; Schmidt N; LeMoine DM; Getaneh S; Xie Z; Phelps MA; Clinton SK; Coss CC
Sci Rep; 2021 Feb; 11(1):3646. PubMed ID: 33574348
[TBL] [Abstract][Full Text] [Related]
20. Branched-chain amino acids ameliorate fibrosis and suppress tumor growth in a rat model of hepatocellular carcinoma with liver cirrhosis.
Cha JH; Bae SH; Kim HL; Park NR; Choi ES; Jung ES; Choi JY; Yoon SK
PLoS One; 2013; 8(11):e77899. PubMed ID: 24223741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]